| scholarly article | Q13442814 |
| P50 | author | Steven Buyske | Q37629979 |
| Bonnie L Firestein | Q50635847 | ||
| P2093 | author name string | Bin Xu | |
| Erik I Charych | |||
| Linda M Brzustowicz | |||
| Naomi Wratten | |||
| P2860 | cites work | Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia | Q22241679 |
| Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia | Q24308818 | ||
| CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95 | Q24336329 | ||
| Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. | Q24531397 | ||
| Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
| Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23 | Q24536215 | ||
| Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia | Q24612644 | ||
| Neuregulin 1 and susceptibility to schizophrenia | Q24616921 | ||
| Evidence for association of schizophrenia with genetic variation in the 8p21.3 gene, PPP3CC, encoding the calcineurin gamma subunit | Q24678549 | ||
| Solution structure and backbone dynamics of the second PDZ domain of postsynaptic density-95 | Q27620876 | ||
| Dexras1: a G protein specifically coupled to neuronal nitric oxide synthase via CAPON | Q28138253 | ||
| Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22 | Q28143069 | ||
| A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly | Q28184095 | ||
| Genes for schizophrenia? Recent findings and their pathophysiological implications | Q28207952 | ||
| Construction and characterization of human brain cDNA libraries suitable for analysis of cDNA clones encoding relatively large proteins | Q28240300 | ||
| Characterization of cDNA clones in size-fractionated cDNA libraries from human brain | Q28261020 | ||
| Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains | Q28278085 | ||
| A genome-wide search for schizophrenia susceptibility genes | Q28283886 | ||
| Whole-genome patterns of common DNA variation in three human populations | Q29616283 | ||
| Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. | Q33909819 | ||
| Long-range control of gene expression: emerging mechanisms and disruption in disease | Q33938801 | ||
| Genetic insights into schizophrenia | Q34203064 | ||
| Association of the carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase gene with schizophrenia in the Chinese Han population | Q34393680 | ||
| HUGE: a database for human KIAA proteins, a 2004 update integrating HUGEppi and ROUGE. | Q40403174 | ||
| The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? | Q40629140 | ||
| Cloning and characterization of postsynaptic density 93, a nitric oxide synthase interacting protein. | Q44667591 | ||
| Linkage of schizophrenia with chromosome 1q loci in Taiwanese families. | Q52550480 | ||
| 1q21-q22 locus is associated with susceptibility to the reality-distortion syndrome of schizophrenia spectrum disorders | Q60460761 | ||
| Fine mapping of the schizophrenia susceptibility locus on chromosome 1q22 | Q73445452 | ||
| Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia | Q73553135 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| bipolar disorder | Q131755 | ||
| P304 | page(s) | e263 | |
| P577 | publication date | 2005-09-13 | |
| P1433 | published in | PLOS MEDICINE | Q1686921 |
| P1476 | title | Increased expression in dorsolateral prefrontal cortex of CAPON in schizophrenia and bipolar disorder | |
| P478 | volume | 2 |
| Q30488182 | Abnormal social behavior, hyperactivity, impaired remote spatial memory, and increased D1-mediated dopaminergic signaling in neuronal nitric oxide synthase knockout mice |
| Q43645946 | Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder |
| Q36316351 | Association of synapsin 2 with schizophrenia in families of Northern European ancestry |
| Q30415434 | Associations between NOS1AP single nucleotide polymorphisms (SNPs) and QT interval duration in four racial/ethnic groups in the Multi-Ethnic Study of Atherosclerosis (MESA) |
| Q24310490 | CAPON modulates cardiac repolarization via neuronal nitric oxide synthase signaling in the heart |
| Q35804105 | CAPON modulates neuronal calcium handling and cardiac sympathetic neurotransmission during dysautonomia in hypertension. |
| Q48600616 | CAPON-nNOS coupling can serve as a target for developing new anxiolytics |
| Q38191484 | Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications. |
| Q36894741 | Chasing genes for mood disorders and schizophrenia in genetically isolated populations |
| Q33323384 | Decreased expression of Sprouty2 in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder: a correlation with BDNF expression |
| Q24814466 | Does the CAPON gene confer susceptibility to schizophrenia? |
| Q92573249 | Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling |
| Q33846861 | Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. |
| Q80182894 | Expression of CAPON after spinal cord injury in rats |
| Q34747276 | Genome-Wide Linkage Scan of Bipolar Disorder in a Colombian Population Isolate Replicates Loci on Chromosomes 7p21–22, 1p31, 16p12 and 21q21–22 and Identifies a Novel Locus on Chromosome 12q |
| Q93035446 | Hepatic nitric oxide synthase 1 adaptor protein regulates glucose homeostasis and hepatic insulin sensitivity in obese mice depending on its PDZ binding domain |
| Q60939091 | Hippo Signaling: Emerging Pathway in Stress-Related Psychiatric Disorders? |
| Q35809300 | Identification of a schizophrenia-associated functional noncoding variant in NOS1AP. |
| Q37465541 | Low Expression of CAPON in Glioma Contributes to Cell Proliferation via the Akt Signaling Pathway |
| Q38249173 | Mechanisms of NOS1AP action on NMDA receptor-nNOS signaling |
| Q37274086 | Meta-analysis of 32 genome-wide linkage studies of schizophrenia. |
| Q33625398 | Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls |
| Q41006812 | NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling |
| Q30355146 | NOS1AP associates with Scribble and regulates dendritic spine development. |
| Q37161526 | NOS1AP in schizophrenia |
| Q24292961 | NOS1AP modulates intracellular Ca(2+) in cardiac myocytes and is up-regulated in dystrophic cardiomyopathy |
| Q34185630 | NOS1AP protein levels are altered in BA46 and cerebellum of patients with schizophrenia |
| Q28576633 | NOS1AP regulates dendrite patterning of hippocampal neurons through a carboxypeptidase E-mediated pathway |
| Q38328635 | Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. |
| Q36003395 | New roles of carboxypeptidase E in endocrine and neural function and cancer |
| Q35558672 | Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons. |
| Q36527286 | Overexpression of Isoforms of Nitric Oxide Synthase 1 Adaptor Protein, Encoded by a Risk Gene for Schizophrenia, Alters Actin Dynamics and Synaptic Function. |
| Q34494844 | Oxidative stress in schizophrenia: An integrated approach |
| Q38790904 | Post-translational regulation of neuronal nitric oxide synthase: implications for sympathoexcitatory states |
| Q35591134 | Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. |
| Q36288960 | Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia. |
| Q36403410 | Schizophrenia genetics: uncovering positional candidate genes |
| Q36756401 | Schizophrenia susceptibility genes: in search of a molecular logic and novel drug targets for a devastating disorder |
| Q37676119 | Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs |
| Q40138323 | The utility of SELENBP1 gene expression as a biomarker for major psychotic disorders: replication in schizophrenia and extension to bipolar disorder with psychosis |
| Q36617376 | Transcriptome alterations in schizophrenia: disturbing the functional architecture of the dorsolateral prefrontal cortex |
| Q48179080 | Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models. |
| Q52316311 | Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype. |
| Q86707829 | [Association of Schizophrenia and its Clinical Implications with the NOS1AP Gene in the Colombian Population] |
| Q51730519 | d-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner. |
Search more.